These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 20020257)

  • 1. Drug-induced liver injury.
    Holt M; Ju C
    Handb Exp Pharmacol; 2010; (196):3-27. PubMed ID: 20020257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiosyncratic drug-induced liver injury: an update on the 2007 overview.
    Hussaini SH; Farrington EA
    Expert Opin Drug Saf; 2014 Jan; 13(1):67-81. PubMed ID: 24073714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: drug-induced liver injury in clinical practice.
    Björnsson E
    Aliment Pharmacol Ther; 2010 Jul; 32(1):3-13. PubMed ID: 20374223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transduction pathways involved in drug-induced liver injury.
    Han D; Shinohara M; Ybanez MD; Saberi B; Kaplowitz N
    Handb Exp Pharmacol; 2010; (196):267-310. PubMed ID: 20020266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man.
    Dragovic S; Vermeulen NP; Gerets HH; Hewitt PG; Ingelman-Sundberg M; Park BK; Juhila S; Snoeys J; Weaver RJ
    Arch Toxicol; 2016 Dec; 90(12):2979-3003. PubMed ID: 27659300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.
    Laifenfeld D; Qiu L; Swiss R; Park J; Macoritto M; Will Y; Younis HS; Lawton M
    Toxicol Sci; 2014 Jan; 137(1):234-48. PubMed ID: 24136188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of immune reactions in drug-induced liver injury (DILI).
    Ju C; Reilly T
    Drug Metab Rev; 2012 Feb; 44(1):107-15. PubMed ID: 22235834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced liver injury: Advances in mechanistic understanding that will inform risk management.
    Mosedale M; Watkins PB
    Clin Pharmacol Ther; 2017 Apr; 101(4):469-480. PubMed ID: 27861792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced liver injury: insights from genetic studies.
    Andrade RJ; Robles M; Ulzurrun E; Lucena MI
    Pharmacogenomics; 2009 Sep; 10(9):1467-87. PubMed ID: 19761370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-Induced liver injury with hypersensitivity features has a better outcome: a single-center experience of 39 children and adolescents.
    Devarbhavi H; Karanth D; Prasanna KS; Adarsh CK; Patil M
    Hepatology; 2011 Oct; 54(4):1344-50. PubMed ID: 21735470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antituberculous drug-induced liver injury: current perspective.
    Devarbhavi H
    Trop Gastroenterol; 2011; 32(3):167-74. PubMed ID: 22332331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury.
    Thakkar S; Chen M; Fang H; Liu Z; Roberts R; Tong W
    Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):31-38. PubMed ID: 28931315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting and preventing acute drug-induced liver injury: what's new in 2010?
    Liss G; Rattan S; Lewis JH
    Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1047-61. PubMed ID: 20615079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic activation and drug-induced liver injury: in vitro approaches for the safety risk assessment of new drugs.
    Gómez-Lechón MJ; Tolosa L; Donato MT
    J Appl Toxicol; 2016 Jun; 36(6):752-68. PubMed ID: 26691983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reactions and organ damage: The liver.
    Licata A
    Eur J Intern Med; 2016 Mar; 28():9-16. PubMed ID: 26827101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of reactive metabolites in drug-induced liver injury.
    Lee KS; Oh SJ; Kim HM; Lee KH; Kim SK
    Arch Pharm Res; 2011 Nov; 34(11):1879-86. PubMed ID: 22139687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approaches to the study of drug-induced liver injury.
    Fontana RJ
    Clin Pharmacol Ther; 2010 Sep; 88(3):416-9. PubMed ID: 20664536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on drug induced liver injury.
    Rangnekar AS; Fontana RJ
    Minerva Gastroenterol Dietol; 2011 Jun; 57(2):213-29. PubMed ID: 21587150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological mechanisms of drug-induced liver injury.
    Ju C
    Curr Opin Drug Discov Devel; 2005 Jan; 8(1):38-43. PubMed ID: 15679170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA-approved drug labeling for the study of drug-induced liver injury.
    Chen M; Vijay V; Shi Q; Liu Z; Fang H; Tong W
    Drug Discov Today; 2011 Aug; 16(15-16):697-703. PubMed ID: 21624500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.